UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000004980
Receipt No. R000005920
Official scientific title of the study Basic analysis of tear/aqueous humor/vitreous fluid/ retinochoroidal tissue/sclera for Chorioretinopathy
Date of disclosure of the study information 2011/01/30
Last modified on 2017/03/29 (Ver. 8)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Basic analysis of tear/aqueous humor/vitreous fluid/ retinochoroidal tissue/sclera for Chorioretinopathy
Title of the study (Brief title) analysis of tear/aqueous humor/Vitreous fluid/ retinochoroidal tissue/sclera
Region
Japan

Condition
Condition Chorioretinopathy(include uveitis), diabetic retinopathy, scleritis, retinal detachment, retinal vein occlusion, malignant lymphoma, epiretinal membrane
Classification by specialty
Ophthalmology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Tissue from horioretinopathy(include uveitis), diabetic retinopathy, scleritis, retinal detachment, retinal vein occlusion, malignant lymphoma, epiretinal membrane were collected during operation, which should become the useful tool for curing the disease. Collected samples were tested by several basic analysis such as real time PCR, ELISA, western blotting and tissue specimen. The sample of vitreous fluid were collected by vitrectomy with using 23 gage or 25 gage needles. The other tissue were collected by scissors. After that, laser treatment apply for spots of dissected area. We investigate the new findings and treatment for the disease that dose not have any effective treatment.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Explanatory
Developmental phase Not applicable

Assessment
Primary outcomes We would not develop the drugs and new treatment method. So, we could not asses from this clinical test. We could asses and hold the clinical condition from the tissue that was collected during operation.
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria The patients who suffered from vitreous opacification, retinal detach, the proliferative change of retina need the operation to cure those disease.
Key exclusion criteria normal condition
Target sample size 100

Research contact person
Name of lead principal investigator Kazuichi Maruyama
Organization Tohoku University Graduate School of Medicine
Division name Ophthalmology
Address 1-1 Seiryo-machi Aobaku, Sendai
TEL 022-717-7294
Email maruyama-k@oph.med.tohoku.ac.jp

Public contact
Name of contact person Kazuichi Maruyama
Organization Tohoku University Graduate School of Medicine
Division name Ophthalmology
Address 1-1 Seiryo-machi Aobaku, Sendai
TEL 022-717-7294
Homepage URL
Email maruyama-k@oph.med.tohoku.ac.jp

Sponsor
Institute Tohoku University Graduate School of Medicine
Institute
Department

Funding Source
Organization Tohoku University Graduate School of Medicine
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs YES
Study ID_1 RBMR-61807
Org. issuing International ID_1 Kyoto Prefectural University of Medicine
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 京都府立医科大学附属病院

Other administrative information
Date of disclosure of the study information
2011 Year 01 Month 30 Day

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2006 Year 06 Month 01 Day
Anticipated trial start date
2006 Year 06 Month 30 Day
Last follow-up date
2017 Year 12 Month 31 Day
Date of closure to data entry
2017 Year 12 Month 31 Day
Date trial data considered complete
2017 Year 12 Month 31 Day
Date analysis concluded
2017 Year 12 Month 31 Day

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results We performed 87 subject of 150 scheduled subjects at Tohoku University Hospital. In our examination, we noticed that sarcoidosis and lymphoma had signature T cell and B cell population in uveitis.
Other related information The tissue collected from patients randomly and prepare for histological section, to detect the infection with using PCR, analyze the cell population. This test perform as forward looking research to detect the relationship between the results and pathogenesis.

Management information
Registered date
2011 Year 01 Month 30 Day
Last modified on
2017 Year 03 Month 29 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005920